alexa Leptadenia pyrotechnica Induces P53-Dependent Apoptosis
ISSN: 2329-6836

Natural Products Chemistry & Research
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Research Article

Leptadenia pyrotechnica Induces P53-Dependent Apoptosis in Colon Cancer Cells

Mohammad A Khasawneh1*, Adrian Koch4, Hanan M Elwy2, Alaaeldin A Hamza2,3 and Regine Schneider-Stock4
1Department of Chemistry, Faculty of Science U.A.E. University, Al-Ain, P.O. Box 17551, UAE
2National Organizations of Drug Control and Research, 6 Abu Hazem St., Giza, Egypt
3Department of Biology, Faculty of Science U.A.E. University, Al-Ain, P.O. Box 17551, UAE
4Experimental Tumorpathology, Institute of Pathology, University of Erlangen-Nürnberg, 91054 Erlangen, Germany
Corresponding Author : Khasawneh MA
Department of Chemistry
Faculty of Science U.A.E University
Al-Ain, P.O. Box 17551, UAE
Tel: 03-7136135
E-mail: [email protected]
Received May 02, 2015; Accepted May 05, 2015; Published May 31, 2015
Citation: Khasawneh MA, Koch A, Elwy HM, Hamza AA, Schneider-Stock R (2015) Leptadenia pyrotechnica Induces P53-Dependent Apoptosis in Colon Cancer Cells. Nat Prod Chem Res 3:177. doi:10.4172/2329-6836.1000177
Copyright: © 2015 Khasawneh MA, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Related article at
DownloadPubmed DownloadScholar Google
 

Abstract

Leptadenia pyrotechnica has been commonly used traditionally for the treatment of tumors in Gulf countries. However, the molecular mechanism of the anti-cancer activity of Leptadenia pyrotechnica remains unclear. In the present study, 80% ethanolic extract of Leptadenia pyrotechnica and its fractions (n-hexane, EA, n-butanol and aqueous) were evaluated for in vitro cytotoxicity against colon cancer cell lines (HCT 116 wild type and HCT 116 p53−/−). The hexane fraction of Leptadenia pyrotechnica (LHE) is identified as the major anti-cancer fraction in Leptadenia pyrotechnica solvent extracts. Cells were incubated with different concentrations of LHE. Cell viability was quantified by crystal violet and MTT assays. Apoptotic cells were determined using Annexin V-propidium iodide (Annexin V/PI) staining and γH2AX assay for damaged DNA. Bax and Bcl-2, caspase-8, 9, 3 protein expression was analyzed by western blotting. LHE decreased cell viability in colon cancer cells in a dose- and time-dependent manner with an IC50 of 100 μg/ml after 24 h. Further experiments on colon cancer cells treated with LHE at 100 μg/ml for 24 h and 48 h revealed that it induces a p53-dependent apoptosis through intrinsic as well as extrinsic pathways. Analysis of DNA fragmentation by flow cytometry and H2AX assay showed a higher apoptotic cell death in p53 wildtype colon cancer cells treated with LHE in comparison to p53-/- cells. Data of western blots further demonstrated that LHE treatment caused activation of caspases, up regulation of Bax and down regulation of Bcl-2 in a time-dependent manner in HCT 116 cell lines. GC-MS analysis of LHE revealed the presence of derivatives of linoleic acid (octadecadienoic), diterpenes (phytol), triterpenes (squalene), and lupeol as the major constituents. These findings collectively suggest that LHE induces apoptosis in HCT 116 cells possibly mediated by ROS generation and involved multiple pathways including extrinsic, intrinsic and caspase-mediated pathways. Our results suggest that LHE may be applied as a potential anti-cancer drug against human colon cancer having intact p53 function.

Keywords

Share This Page

Additional Info

Loading
Loading Please wait..
 
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords